联系客服

600479 沪市 千金药业


首页 公告 千金药业:千金药业2024年半年度主要经营数据公告

千金药业:千金药业2024年半年度主要经营数据公告

公告日期:2024-08-28

千金药业:千金药业2024年半年度主要经营数据公告 PDF查看PDF原文

  证券代码:600479      证券简称:千金药业        公告编号:2024-036
            株洲千金药业股份有限公司

          2024 年半年度主要经营数据公告

  本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。

  根据《上市公司行业信息披露指引第六号——医药制造》及
《关于做好主板上市公司 2024 年半年度报告披露工作的重要提醒》的要求,公司现将 2024 年第半年度主要经营数据披露如下:

  一、报告期内公司主营业务分行业经营情况

                                              单位:元 币种:人民币

                                                营业  营业

                                                收入  成本  毛利率
                                          毛利  比上  比上  比上年
 分行业    营业收入        营业成本      率  年同  年同  同期增
                                          (%)  期增  期增    减

                                                  减    减    (%)
                                                (%) (%)

 药品生                                                            减少

  产    934,987,588.46  299,240,749.95  68.00  4.68  5.60  0.28 个
                                                                    百分点

 中药材                                                            减少

 及饮片    56,920,040.22    49,231,176.15  13.51  1.21  20.24  13.69

  生产                                                            个百分
                                                                    点

 药品批                                                            减少

 发零售  859,121,294.68  707,975,613.80  17.59  -1.80  -1.37  0.36 个
                                                                    百分点

                                                                    减少

  其他    84,846,578.78    32,826,832.75  61.31  -1.00  3.31  1.61 个
                                                                    百分点

 合并抵  -48,219,537.01  -48,417,602.45

  销


                                                                  增加

 合计  1,887,655,965.13 1,040,856,770.20  44.86  0.77  0.40  0.20 个
                                                                  百分点

  二、报告期内公司主营业务分产品经营情况

                                    单位:元 币种:人民币

                                              营业  营业

                                              收入  成本

                                        毛利  比上  比上  毛利率
 分产      营业收入        营业成本      率  年同  年同  比上年
 品                                    (%  期增  期增  同期增
                                          )    减    减  减(%)
                                              (%)  (%

                                                      )

中药生                                                          减少

 产    483,871,937.65    163,230,121.23  66.27  1.46  6.18  1.50 个
                                                                百分点

西药生                                                          增加

 产    451,115,650.81    136,010,628.72  69.85  8.37  4.91  0.99 个
                                                                百分点

中药材                                                    20.2  减少

及饮片  56,920,040.22    49,231,176.15  13.51  1.21    4  13.69 个
 生产                                                            百分点

药品批                                                      -  减少

发零售  859,121,294.68    707,975,613.80  17.59  -1.80  1.37  0.36 个
                                                                百分点

                                                    -      -  减少

 娱乐    14,994,592.96    5,953,095.60  60.30  15.20  13.5  0.74 个
                                                            8  百分点

卫生用                                                          减少

 品    66,069,419.60    24,582,100.87  62.79  1.31  3.97  0.95 个
                                                                百分点

                                                          84.3  减少

 其他    3,782,566.22      2,291,636.28  39.42  34.95    3  16.23 个
                                                                百分点

合并抵  -48,219,537.01    -48,417,602.45

 消

                          1,040,856,770.2                      增加

 合计  1,887,655,965.13        0        44.86  0.77  0.40  0.20 个
                                                                百分点

  三、报告期内公司主营业务分地区经营情况

                                                单位:元 币种:人民币

    地区      2024 年 1-6 月累计主营业务收入  营业收入比上年同期增减
                                                      (%)

    华东            218,451,288.90                  -1.33

    华南            134,832,098.45                  3.19

    华北              80,948,510.14                  -3.10

    华中            1,163,244,644.98                1.12

    东北              38,662,174.55                  -5.42

    西南            165,287,497.84                  6.14

    西北              86,229,750.27                  -5.00

    合计              1,887,655,965.13                  0.77

  上述的主要经营数据信息来源于公司报告期内财务数据,且未经审计,敬请广大投资者审慎使用,注意风险。

  特此公告。

                                  株洲千金药业股份有限公司
                                          董事会

                                      2024 年 8 月 28 日

[点击查看PDF原文]